Susquehanna International Group
DBTX

Susquehanna International Group’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Susquehanna International Group’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,846
Closed -$39.8K – 14327
2022
Q1 		$51K Sell
16,846
-22,580
-57% -$86.5K ﹤0.01% 12307
2021
Q4 		$183K Buy
39,426
+17,000
+76% +$117K ﹤0.01% 11555
2021
Q3 		$173K Buy
+22,426
New +$171K ﹤0.01% 11648
2021
Q2 		– Sell
-14,291
Closed -$162K – 13478
2021
Q1 		$162K Buy
+14,291
New +$224K ﹤0.01% 11593

Other funds holding DBTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's DBTX Position: Q2 2022 in Review

Susquehanna International Group sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q2 2022, closing a stake of 16,846 shares — an estimated $39.8K sold.

Susquehanna International Group first reported a position in DBTX in Q1 2021 and held it in 4 quarters. The position peaked at $183K in Q4 2021. 42 funds tracked by Wall St. Rank hold DBTX as of Q2 2022.

  • Susquehanna International Group reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Susquehanna International Group sold 16,846 Decibel Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $39.8K.
  • Susquehanna International Group first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Susquehanna International Group's Decibel Therapeutics, Inc. Common Stock position peaked at $183K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.